MDLN vs. UHS: Medline vs. Universal Health Services Stock Comparison

Company Profile

Medline (MDLN) and Universal Health Services (UHS) both fall under the Health Care Equipment & Services industry group, but MDLN is classified in Health Care Equipment & Supplies while UHS is classified in Health Care Providers & Services.

Universal Health Services (UHS) has been public since July 9, 1981, giving it decades of market history across multiple cycles, while Medline (MDLN) listed only on December 17, 2025 and lacks comparable through-cycle data.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Medline (MDLN) reports a negative beta of -0.93, suggesting inverse market sensitivity over the measurement window. That is uncommon for ordinary equities and can reflect commodity-linked or hedge-like exposure, but it can also come from statistical noise. Universal Health Services (UHS) has a non-negative beta of 1.06.

Risk-Adjusted Performance

Risk-Return Positioning

Both MDLN and UHS need 1-year volatility and 1-year return to plot risk-return positioning.

Risk-Adjusted Metrics

Profitability

Universal Health Services (UHS) at 19.74% sits in the top ROE quartile, while Medline (MDLN) at 4.85% is closer to the peer norm — stronger capital efficiency for UHS.

Both Medline (MDLN) at 1.85% and Universal Health Services (UHS) at 7.97% keep about the typical share of revenue as profit for their industries — neither bottom line stands out from peers.

Both Medline (MDLN) at 5.22% and Universal Health Services (UHS) at 9.60% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.

Profitability Metrics

Growth

Only one side can be read here: Universal Health Services (UHS) reports revenue growth of 9.71%, ranked against its industry; Medline (MDLN) has no revenue growth figure this period.

Both companies show strong earnings momentum, but Medline (MDLN) at 117.38% is the standout with EPS growth above its industry range; Universal Health Services (UHS) at 37.34% also sits in the top quartile.

Growth Metrics

Financial Strength

Universal Health Services (UHS) at 1.37 keeps current ratio within its industry’s typical mid-range, while Medline (MDLN) at 4.04 sits above its industry’s typical mid-range — comfortable liquidity, though possibly with more idle current assets relative to peers.

Both Medline (MDLN) at 0.65 and Universal Health Services (UHS) at 0.80 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

Financial Strength Metrics

Dividends

Medline (MDLN) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Universal Health Services (UHS) reports a yield of 0.10%, ranking against industry peers normally.

Medline (MDLN) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Universal Health Services (UHS) reports a payout of 3.35%, ranking against industry peers normally.

Dividend Metrics

Valuation

Universal Health Services (UHS) at 8.18 sits in the cheaper P/E ratio quartile, while Medline (MDLN) at 90.09 trades above its peer range — a wide earnings-valuation gap relative to industry peers.

Universal Health Services (UHS) at 0.63 sits in the cheaper P/S ratio quartile while Medline (MDLN) at 1.70 prices around its industry’s middle — UHS costs less per dollar of sales, though read it alongside growth and margins.

Universal Health Services (UHS) at 1.51 sits in the lower P/B ratio quartile against book while Medline (MDLN) at 2.95 is valued near its industry’s middle — UHS is cheaper on assets, though weigh it against ROE and asset quality.

Valuation Metrics